Tekla Healthcare Investors Stock Fundamentals
| HQH Stock | USD 16.95 0.01 0.06% |
Tekla Healthcare Investors fundamentals help investors to digest information that contributes to Tekla Healthcare's financial success or failures. It also enables traders to predict the movement of Tekla Stock. The fundamental analysis module provides a way to measure Tekla Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tekla Healthcare stock.
As of now, Tekla Healthcare's Operating Income is increasing as compared to previous years. The Tekla Healthcare's current Net Interest Income is estimated to increase to about 748.7 K, while Depreciation And Amortization is projected to decrease to under 1 M. Tekla | Select Account or Indicator |
Tekla Healthcare Investors Company Profit Margin Analysis
Tekla Healthcare's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Tekla Healthcare Profit Margin | 5.47 % |
Most of Tekla Healthcare's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tekla Healthcare Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tekla Profit Margin Historical Pattern
Today, most investors in Tekla Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tekla Healthcare's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's profit margin growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Tekla Healthcare profit margin as a starting point in their analysis.
Tekla Healthcare Profit Margin |
| Timeline |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Tekla Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Tekla Healthcare Investors has a Profit Margin of 5.4737%. This is 53.06% lower than that of the Capital Markets sector and 65.11% lower than that of the Financials industry. The profit margin for all United States stocks is notably lower than that of the firm.
Tekla Healthcare Inv Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tekla Healthcare's current stock value. Our valuation model uses many indicators to compare Tekla Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tekla Healthcare competition to find correlations between indicators driving Tekla Healthcare's intrinsic value. More Info.Tekla Healthcare Investors is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . As of now, Tekla Healthcare's Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tekla Healthcare's earnings, one of the primary drivers of an investment's value.Tekla Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tekla Healthcare's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tekla Healthcare could also be used in its relative valuation, which is a method of valuing Tekla Healthcare by comparing valuation metrics of similar companies.Tekla Healthcare is currently under evaluation in profit margin category among its peers.
Tekla Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Tekla Healthcare from analyzing Tekla Healthcare's financial statements. These drivers represent accounts that assess Tekla Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Tekla Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 904.6M | 1.1B | 818.1M | 768.8M | 884.1M | 1.0B | |
| Enterprise Value | 907.1M | 1.1B | 826.6M | 768.8M | 884.1M | 1.0B |
Tekla Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Tekla Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tekla Healthcare's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Tekla Fundamentals
| Return On Equity | 0.061 | ||||
| Return On Asset | -8.0E-4 | ||||
| Profit Margin | 5.47 % | ||||
| Operating Margin | (0.22) % | ||||
| Current Valuation | 838.54 M | ||||
| Shares Outstanding | 50.62 M | ||||
| Shares Owned By Institutions | 27.04 % | ||||
| Number Of Shares Shorted | 36.82 K | ||||
| Price To Earning | 3.38 X | ||||
| Price To Book | 0.85 X | ||||
| Price To Sales | 76.62 X | ||||
| Revenue | 58.12 M | ||||
| Gross Profit | 8.27 M | ||||
| EBITDA | 56.33 M | ||||
| Net Income | 56.33 M | ||||
| Cash And Equivalents | 62 | ||||
| Total Debt | 1.15 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 3.21 X | ||||
| Book Value Per Share | 18.84 X | ||||
| Cash Flow From Operations | (65.41 M) | ||||
| Short Ratio | 0.89 X | ||||
| Earnings Per Share | 1.09 X | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 858.6 M | ||||
| Total Asset | 932.49 M | ||||
| Retained Earnings | 5.97 M | ||||
| Annual Yield | 0.1 % | ||||
| Five Year Return | 8.90 % | ||||
| Net Asset | 932.49 M | ||||
| Last Dividend Paid | 1.61 |
About Tekla Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 66.8 M | 70.2 M | |
| Cost Of Revenue | 12.5 M | 7.3 M | |
| Sales General And Administrative To Revenue | 0.02 | 0.02 | |
| Revenue Per Share | 1.35 | 1.17 | |
| Ebit Per Revenue | 1.11 | 1.09 |
Currently Active Assets on Macroaxis
| VTSNX | Vanguard Total International | |
| VBTIX | Vanguard Total Bond | |
| VMCIX | Vanguard Mid Cap Index | |
| GOOGL | Alphabet Inc Class A | |
| AMZN | Amazon Inc |
Additional Information and Resources on Investing in Tekla Stock
When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:Check out Tekla Healthcare Piotroski F Score and Tekla Healthcare Altman Z Score analysis. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.67) | Dividend Share 1.61 | Earnings Share 1.09 | Revenue Per Share 0.208 | Quarterly Revenue Growth 0.081 |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.